Anavo Therapeutics BV

About Anavo Therapeutics BV

Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.

We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications.

Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.

Keywords

• Drug Discovery
• Oncology
• Phospatase Biology

Address

• Headquarters

  J.H. Oortweg 192333CH LeidenZuid-Holland, Netherlands

Team by function

Based on 2 public job profiles as of 4 September 2026.

• Executive / C-Suite2